Mitochondrial DNA polymerase-
and human disease
Mitochondrial Research Group and Institute of Human Genetics, M41014, The Medical School, Framlington Place, Newcastle upon Tyne NE2 4HH, UK
* To whom correspondence should be addressed. Tel: +44 1912228334; Fax: +44 1912228553; Email: p.f.chinnery{at}ncl.ac.uk
Received June 19, 2006; Accepted August 14, 2006
The maintenance of mitochondrial DNA (mtDNA) is critically dependent upon polymerase-
(pol-), encoded by the nuclear gene POLG. Over the last 5 years, it has become clear that mutations of POLG are a major cause of human disease. Secondary mtDNA defects characterize these disorders, with mtDNA depletion, multiple mtDNA deletions or multiple point mutations of mtDNA in clinically affected tissues. The secondary mtDNA defects cause cell and tissue-specific deficiencies of mitochondrial oxidative phosphorylation, leading to organ dysfunction and human disease. Functional genetic variants of POLG are present in up to 
0.5% of the general population, and pathogenic mutations have been described in most exons of the gene. Clinically, POLG mutations can present from early neonatal life to late middle age, with a spectrum of phenotypes that includes common neurological disorders such as migraine, epilepsy and Parkinsonism. Transgenic mice and biochemical studies of recombinant mutated proteins are helping to unravel mechanisms of pathogenesis, and patterns are beginning to emerge relating genotype to phenotype.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  I. Bratic, J. Hench, J. Henriksson, A. Antebi, T. R Burglin, and A. Trifunovic Mitochondrial DNA level, but not active replicase, is essential for Caenorhabditis elegans development Nucleic Acids Res., April 1, 2009; 37(6): 1817 - 1828. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Giordano, H. Powell, M. Leopizzi, M. de Curtis, C. Travaglini, M. Sebastiani, P. Gallo, R. W. Taylor, and G. d'Amati FATAL CONGENITAL MYOPATHY AND GASTROINTESTINAL PSEUDO-OBSTRUCTION DUE TO POLG1 MUTATIONS Neurology, March 24, 2009; 72(12): 1103 - 1105. [Full Text] [PDF]
|
|
|
|
 |
|
 N. Ashley, A. O'Rourke, C. Smith, S. Adams, V. Gowda, M. Zeviani, G. K. Brown, C. Fratter, and J. Poulton Depletion of mitochondrial DNA in fibroblast cultures from patients with POLG1 mutations is a consequence of catalytic mutations Hum. Mol. Genet., August 15, 2008; 17(16): 2496 - 2506. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Kim, C. Jardel, C. Barthelemy, V. Jan, J. P. Bastard, S. Fillaut-Chapin, S. Houry, J. Capeau, and A. Lombes Mitochondrial DNA Content, an Inaccurate Biomarker of Mitochondrial Alteration in Human Immunodeficiency Virus-Related Lipodystrophy Antimicrob. Agents Chemother., May 1, 2008; 52(5): 1670 - 1676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kukat, C. Kukat, J. Brocher, I. Schafer, G. Krohne, I. A. Trounce, G. Villani, and P. Seibel Generation of {rho}0 cells utilizing a mitochondrially targeted restriction endonuclease and comparative analyses Nucleic Acids Res., April 1, 2008; 36(7): e44 - e44. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Amati-Bonneau, M. L. Valentino, P. Reynier, M. E. Gallardo, B. Bornstein, A. Boissiere, Y. Campos, H. Rivera, J. G. de la Aleja, R. Carroccia, et al. OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes Brain, February 1, 2008; 131(2): 338 - 351. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Harrower, J. D. Stewart, G. Hudson, H. Houlden, G. Warner, D. G. O'Donovan, L. J. Findlay, R. W. Taylor, R. De Silva, and P. F. Chinnery POLG1 Mutations Manifesting as Autosomal Recessive Axonal Charcot-Marie-Tooth Disease Arch Neurol, January 1, 2008; 65(1): 133 - 136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. J. Krishnan, L. C. Greaves, A. K. Reeve, and D. Turnbull The ageing mitochondrial genome Nucleic Acids Res., December 3, 2007; 35(22): 7399 - 7405. [Abstract] [Full Text] [PDF]
|
|